In an era where expectant parents desire more knowledge about their unborn child’s health from the earliest stages, noninvasive prenatal screening (NIPS) has emerged as a game-changer. Offering a semblance of reassurance, these tests provide insight into possible genetic disorders with minimal risk. By requiring only a small sample of blood from the mother, NIPS
4 Weeks
Prenatal genetic screening has become a staple component of early pregnancy care. Designed to provide reassurance and insights into the well-being of an unborn child, screening tests have gained popularity among expectant parents. However, as recent discussions regarding the accuracy and reliability of these tests have unfolded, it is imperative to scrutinize their implications thoroughly.